Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Low-Dose Antithymocyte Globulin in Type 1 Diabetes: Real-World Exploratory Observation of C-Peptide by Modified Quantitative Response (mQR).
Journal: Diabetes care
Published: January 28, 2026
Systemic mRNA vaccines elicit rapid immune activation in canine brain tumors.
Journal: Journal for immunotherapy of cancer
Published: September 10, 2025
Serotonin, immune function, and psychedelics as potent anti-inflammatories.
Journal: International review of neurobiology
Published: June 20, 2025
Emerging Immunotherapies for Disease Modification of Type 1 Diabetes.
Journal: Drugs
Published: January 13, 2025
Comment on Lombardo et al. The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes. Children 2022, 9, 1087.
Journal: Children (Basel, Switzerland)
Published: December 12, 2024
Therapeutic mRNA vaccine applications in oncology.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 11, 2024
Pilot Study: Improving Glycemic Control Among Children and Adolescents With Obesity and Prediabetes With Real-Time Feedback Via Continuous Glucose Monitoring.
Journal: Diabetes spectrum : a publication of the American Diabetes Association
Published: August 12, 2024
Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression.
Journal: ACS pharmacology & translational science
Published: October 24, 2023
Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes.
Journal: Diabetes care
Published: September 15, 2023
Last Updated: 09/26/2026